Haematology Strong — IMWG R-ISS 2015
Revised ISS (R-ISS) for Multiple Myeloma
Revised International Staging System for Multiple Myeloma incorporating ISS stage, LDH, and high-risk cytogenetics.
References
- Palumbo A et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol. 2015.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Bortezomib · Proteasome Inhibitor — Myeloma
- Noradrenaline (Norepinephrine) · Vasopressor (Alpha-1 and Beta-1 Agonist)
- Dobutamine (ICU — Inotrope) · Inotrope (Beta-1 Agonist)
- Labetalol (IV — Hypertensive Emergency) · Combined Alpha-1 and Beta-Adrenergic Blocker
- Ephedrine hydrochloride · Mixed alpha/beta-adrenergic agonist (vasopressor)
- Sotalol · Antiarrhythmic
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
- Anticoagulation Reversal · BSH 2016 / ESC
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.